United States · Wires & real time · Bloomberg
Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Detailed summary
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)
